Aftershocks of Cancer Chemotherapy: Managing Adverse Effects-Reference-Cited by-同舟云学术

Aftershocks of Cancer Chemotherapy: Managing Adverse Effects

Published:2007-01-01 Issue:1 Volume:43 Page:1-7
ISSN:0587-2871
Container-title:Journal of the American Animal Hospital Association
language:en
Short-container-title:

Author:

Thamm Douglas H.¹²³,Vail David M.¹²³

Affiliation:

1. The Animal Cancer Center (Thamm), College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado 80523; and the

2. Department of Medical Sciences (Vail), School of Veterinary Medicine, University of Wisconsin – Madison, Madison, Wisconsin 53704

3. From the

Abstract

Most cytotoxic chemotherapy protocols used in small animals are designed to have a low risk of adverse effects; however, adverse events can occasionally occur. Timely and appropriate management of adverse events greatly increases client satisfaction and the likelihood of a successful treatment outcome. This article presents guidelines for the management of chemotherapy-associated hematological and gastrointestinal disturbances, extravasation injury, and anaphylaxis.

Publisher

American Animal Hospital Association

Subject

Small Animals

Link

http://meridian.allenpress.com/jaaha/article-pdf/43/1/1/1331040/0430001.pdf

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A rapid manual technique does not have adequate sensitivity and specificity to reliably discriminate between neutropenic and non‐neutropenic dogs prior to administration of chemotherapy;Journal of Small Animal Practice;2024-08-06

2. Management of the Immunosuppressed Patient;Infection Control in Small Animal Clinical Practice;2023-05-02

3. Plasma Cytokeratin 18 and fecal Alpha‐1 Antitrypsin concentrations in dogs with osteosarcoma receiving carboplatin chemotherapy;Veterinary Medicine and Science;2020-11-22

4. Evaluation of a 0.75 × 10 9 /L absolute neutrophil count cut‐off for antimicrobial prophylaxis in canine cancer chemotherapy patients;Veterinary and Comparative Oncology;2019-10-16

5. Assessment of the administration of maropitant and loperamide to dogs with cancer for the prevention and reduction of adverse effects associated with the administration of paclitaxel;American Journal of Veterinary Research;2019-06